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Abstract: Background: Endotracheal intubation and carbon dioxide pneumoperitoneum in patients undergoing 
laparoscopic cholecystectomy changes hemodynamic parameters. According to magnesium effect on the inhibition 
of catecholamine release and attenuate vasopressin-stimulated vasoconstriction, this study was performed to reduce 
the hemodynamic effects during tracheal intubation and pneumoperitoneum in patients undergoing laparoscopic 
cholecystectomy. Material and methods: In prospective triple-blind clinical trial, 60 patients 18- 70 years old 
undergoing laparoscopic cholecystectomy were randomly assigned to one of two groups: intervention group (30 
mg/kg magnesium sulfate) and control group (1.5 mg/kg lidocaine). Heart rate and mean arterial pressure were 
recorded before laryngoscopy (baseline value), immediately and every minute after intubation until 5 minute and 
before and 5, 10, 15, 30 min after pneumoperitoneum. Results: Mean arterial pressure was low in magnesium 
sulfate group than control group throughout the study period and was statistically significant at before insufflation 
and 5 minute after insufflation (p=0.005). Heart rate in magnesium sulfate group was higher than control group 
throughout the study period (P>0.05). Conclusion: Using magnesium sulfate 30 mg/kg in patients undergoing 
laparoscopic cholecystectomy can attenuate mean arterial pressure change in pneumoperitoneum than lidocaine. 
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Introduction: 
Laryngoscopy and tracheal intubation cause 
airway protective reflexes that lead to physiological 
changes involving various body systems. Reflex 
changes in the cardiovascular system is often created 
after Laryngoscopy and tracheal intubation and caused 
increasing 40-50% blood pressure and increasing 20% 
heart rate (1). 
In Laparoscopic Cholecystectomy, CO2 gas is 
used for pneumoperitoneum (PP) that blowing CO2 
gas and PP cause cardiovascular responses. 
Cardiovascular changes include increased arterial 
blood pressure and increased systemic vascular 
resistance and decreased cardiac output because of 
increased plasma catecholamine or vasopressin, or 
both. Increased heart rate and blood pressure can be 
dangerous for patients, particularly those with 
impaired cardiac function (2). Alpha2-adrenergic 
agonists, beta-blocking agents, opioids, or vasodilators 
are often used to avoid circulatory response to 
pneumoperitoneum (3,4). 
For years, Intravenous Magnesium Sulfate 
(MgSO4) was used as an antiarrhythmic agent and for 
prophylaxis against seizures in preeclampsia and 
recently importance of Magnesium has changed to be 
the center of attention in anesthesia and surgery (2). 
Magnesium sulfate inhibits the release of 
catecholamines from the medulla part of adrenal and 
peripheral nerve endings, and also causes sympathetic 
blocks and indirectly causes dilation of blood vessels 
and thus blood pressure reduction (5,6). 
The effect of Magnesium Sulfate prescription to 
reduce the hemodynamic response during tracheal 
intubation and Pneumoperitoneum compared with 
placebo was shown in studies such as the study of 
Misbah Kia et.al in 2014 on CABG patients (7), the 
study of Paul et.al in 2013 on laparoscopic 
cholecystectomy surgery (2) and Dar et.al study in 
2015 on abdominal laparoscopic surgery (8). Although 
some studies such as Dehgani Firosabadi et.al in 2014 
(9) have shown that magnesium sulfate doesn't have 
effects on hemodynamic changes following 
laryngoscopy and tracheal intubation. 
Given that currently in the majority of 
laparoscopic cholecystectomy, intravenous lidocaine is 
used as a premedication in order to decrease 
hemodynamic changes after tracheal intubation and 
Pneumoperitoneum, but despite these, hemodynamic 
changes especially after insufflation CO2 gas are still 
considerable. Due to the favorable impact of 
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magnesium sulfate on patients’ hemodynamic 
responses (10,11,12), this study was performed in 
purpose of comparing magnesium sulfate with 
lidocaine to reduce hemodynamic responses after 
tracheal intubation and Pneumoperitoneum in patients 
undergoing laparoscopic cholecystectomy. 
 
Materials and methods: 
In this triple blind clinical trial study, 60 patients 
of ASA class I and II aged between 18-70 years of 
either sex candidate for laparoscopic cholecystectomy 
surgery, were included after obtaining the approval of 
university ethics committee, IRCT2016022716612N6 
and written consent from the patients, in Imam 
Khomeini Hospital in Ardebil. Exclusion criteria were 
allergy to magnesium sulfate, hypermagnesemia, high 
blood pressure, gastro esophageal reflux disease, 
pregnancy, lactation, heart, liver and kidney diseases, 
history of drug addiction and alcoholism, BMI>30 and 
neuromuscular disease. The patients were randomly 
assigned into two groups of 30each using a computer-
generated block-randomized number table. 
Randomization was performed by a statistical expert 
who was blinded to the study design. Immediately 
before induction of anesthesia, 30 mg/kg intravenous 
magnesium sulfate was administered for intervention 
group and 1.5 mg/kg Lidocaine by adding sterile water 
to reach the same volume magnesium sulfate was 
administered for control group. Drugs were prepared 
in the same unlabeled syringe containing equal volume 
by anesthesia resident and drug injection was 
conducted by the anesthesiologist who was blinded to 
the randomization. Then patients received 1 mg 
Midazolam, 2 μg/kg Fentanyl, 2 mg/kg Propofol and 
0.5 mg/kg Atracurium endotracheal as muscle 
relaxant. Tracheal intubation was done 3 minutes after 
drug injection. After intubation, anesthesia was kept 
on with 100 μg/kg/m Propofol infusion, along with the 
inspiratory gas mixture (50% oxygen and 50% N2O). 
To maintain muscle relaxation, 0.5 mg/kg Atracurium 
was injected intermittent boluses and the patients were 
mechanically ventilated during surgery. Tidal volume 
and respiratory rate were adjusted to maintain end-
tidal CO2 between 35-45mm Hg. After insufflation 
CO2 with 12 mmHg intra-abdominal pressure (IAP) 
into the peritoneum, patients were placed on head up 
tilt position at 15º. In all patients monitoring of HR, 
SBP, DBP, MBP, SpO2, ETCO2 and TOF was done 
on a multichannel and TOF monitor. In case of 
hemodynamic changes such as bradycardia, 
hypotension or hypertension, therapeutic interventions 
have been done. For bradycardia (HR <50) 0.5 mg 
Atropine bolus was used and increased amount of 
intravenous fluid infusion or intravenous bolus doses 
of 5 mg Ephedrine were used for hypotension (MAP 
<60). For hypertension (MAP> 110) Nitroglycerine 
infusion was started. At the end of surgery all 
administered anesthetic drugs were interrupted and 
100% oxygen about 6 L/min was given to patients. 
Following spontaneous respiration, muscle relaxation 
was reversed with injection of Neostigmine and 
Atropine and after establishing proper breathing; 
patients were extubated and transferred to the recovery 
room. 
HR and MAP were recorded as follows:  
1. Baseline vital signs 
2. Before laryngoscopy 
3. Immediately after laryngoscopy 
4. In 1,2,3,4,5 minutes after tracheal intubation  
5. Before insufflation CO2 
6. 5 minutes after insufflation CO2 
7. 10 minutes after insufflation CO2 
8. 15 minutes after insufflation CO2 
9. 30 minutes after insufflation CO2 
The sample size was calculated on the basis of 
previous studies (2), for detecting clinically significant 
reduction of %25 in hemodynamic changes, assuming 
a power of 80% and a significance level of 5%. 
All raw data of study parameters were entered 
and analyzed using SPSS v21.0. Data was presented as 
mean and standard deviation (SD) or numbers with 
percentage. Independent 
T-testand, repeated measure in order to compare 
the means (for quantitative data) and Chi-square tests 
(for qualitative data) were used to determine 
differences between the experimental and control 
group. P-values<0.05 were considered statistically 
significant. 
 
Results: 
The distribution of patients in two groups is 
shown as Table 1. 
 
Table 1: Demographic characteristics and baseline vitals of patients 
variable Mg sulfate (N=30) Control (N=30) P value 
Sex (M/F) 5/25 3/27 0.71 
Age (mean ± SD) 42.73±11.61 44.17±14.7 0.68 
Weight (mean ± SD) 70.87±12.76 75.53±18.68 0.26 
Height (mean ± SD) 159.52±7.23 162.03±8.02 0.21 
Duration of surgery (mean ± SD) 51.20±23.85 48.17±13.72 0.54 
Duration of Anesthesia (mean ± SD) 74.57±26.01 78.13±19.44 0.55 
MAP (mean ± SD) 102.97±14.58 107.77±16.02 0.23 
Heart rate (mean ± SD) 91.67±20.99 85.30±18.63 0.22 
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Mean arterial pressure was low in magnesium 
sulfate group than control group throughout the study 
period (except in before and 1 minute after 
laryngoscopy) (Figure 1) and was statistically 
significant at before insufflation and 5 minute after 
insufflation (p=0.005). 
 
Figure1: Variations in Mean Arterial Pressure in 2 groups during the study 
 
Heart rate in magnesium sulfate group was 
higher than control group throughout the study period 
(Figure 2) and was statistically significant at before 
laryngoscopy (p=0.001). Heart rate fluctuations in the 
magnesium sulfate group were lower than lidocaine 
group during surgery, especially before and after 
laryngoscopy, and before and after insufflation CO2 
gas, but this difference was not statistically significant 
(P >0.05 ).  
  
Figure 2: Variations in Heart rate in 2 groups during the study 
 
 Biomedicine and Nursing 2018;4(1)   http://www.nbmedicine.org 
 
30 
Only one patient in magnesium sulfate group in 
comparison whit 3 patients in lidocaine group suffered 
from bradycardia (Pvalue=0.61). Hypotension 
occurred in one patient in each group, and one patient 
in lidocaien group suffered from hypertension 
(Pvalue=1). 
 
Discussion:  
The findings of our study on the effect of 
magnesium sulfate premedication on heart rate in 
comparison with lidocaine showed that heart rate 
fluctuations in the magnesium sulfate group were 
lower than lidocaine group during surgery, especially 
before and after laryngoscopy, and before and after 
insufflation CO2 gas, but this difference was not 
statistically significant (P >0.05 ). The study on the 
mean blood pressure showed that mean blood pressure 
in the magnesium sulfate group was significantly 
lower than that for lidocaine group (P < 0.001), and 
mean blood pressure during the period before and after 
insufflation CO2 gas in magnesium sulfate group was 
statistically significant (P < 0.005) lower than that in 
the lidocaine group. 
In Panda et.al (13) study was performed in 
patients with high blood pressure who were 
undergoing surgery and intubation, MAP was 
maintained in the normal range during the surgery in a 
group that was received 30mg/kg Magnesium sulfate, 
but in lidocaine group, 3 and 4 min after intubation 
had a significant decrease compared to the baseline. 
Also in our study, blood pressure in magnesium sulfate 
group which was somewhat lower than that in 
lidocaine group is consistent with the results of this 
study. 
In shamim et.al. (14) and in Zarif et.al (15) 
studies were performed on hemodynamic changes 
during laparoscopic cholecystectomy after infusion of 
magnesium sulfate and placebo, the results showed 
that magnesium sulfate effectively attenuates 
hemodynamic responses during intubation and 
pneumoperitoneum in laparoscopic cholecystectomy 
than placebo compared to the baseline which was 
consistent with our study. 
In a study by Paul et.al. (2), effects of magnesium 
sulfate on hemodynamic response to carbon dioxide 
pneumoperitoneum in patients undergoing 
laparoscopic cholecystectomy, MAP in the group who 
received magnesium sulfate during PP was 
significantly less than placebo group and had less 
fluctuations than baseline (P < 0.05). The heart rate in 
patients who received magnesium sulfate during PP 
was significantly lower than placebo group (P < 0.05 ). 
In Ahmad Dar et. al. study (8), on the effect of 
magnesium sulfate on reducing hemodynamics stress 
responses during abdominal laparoscopic surgery, 
mean heart rate in magnesium sulfate group was lower 
than in the placebo group during surgery, after 
intubation, especially 10 minutes after creating 
pneumoperitoneum (P < 0.05 ) and Systolic blood 
pressure, Diastolic blood pressure, Mean arterial 
pressure was low in magnesium sulfate group than 
placebo group throughout the study period and were 
statistically significant (p<0.05). In both above 
mentioned studies, placebo is used in comparison with 
Magnesium sulfate that justifies the significance of 
obtained results. Our results revealed that, increasing 
blood pressure after insufflation CO2 in magnesium 
sulfate group compared to lidocaine group was low. 
In a study by Jee et.al. (4) " Magnesium sulphate 
attenuates arterial pressure increase during 
laparoscopic cholecystectomy", Systolic and diastolic 
blood pressure significantly (p<0.05) were greater in 
the placebo group than in the magnesium sulfate group 
at 10,20, and 30 min post pneumoperitoneum. But 
there were no significant differences in patients' heart 
rate in duration of surgery between two groups (P > 
0.05 ). In our study, there was not a significant 
difference in patients' heart rate during surgery in both 
groups but heart rate fluctuations were significantly 
lower in magnesium sulfate group. 
In our study only one patient in magnesium 
sulfate group in comparison whit 3 patients in 
lidocaine group suffered from bradycardia 
(Pvalue=0.61). Hypotension occurred in one patient in 
each group, and one patient in lidocaien group suffered 
from hypertension (Pvalue=1). This shows that 
magnesium sulfate provides more hemodynamic 
stability than lidocaine during surgery. 
In the study of Paul et.al. (2) none of the patients 
required atropine but just only one hypotension case in 
magnesium sulfate group required medical 
interventions. Hypertension occurred in 12 patient of 
control group whereas no patients of magnesium 
sulfate group suffered from hypertension.  
In study conducted by Ahmad Dar et.al (8) was 
about the effect of magnesium sulfate on reducing 
hemodynamics stress during abdominal laparoscopic 
surgery, none of the patients required medical 
interventions. 
The limitations of this study are not study of 
different dosage of magnesium sulphat and lack of 
patients adequate follow-up for the side effects 
occurrence in both groups. 
 
Conclusion: 
Using magnesium sulfate 30 mg/kg in patients 
undergoing laparoscopic cholecystectomy can 
attenuate mean arterial pressure change in 
pneumoperitoneum and provides more hemodynamic 
stability than lidocaine during surgery. 
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